SSBP2 and pachyonychia congenita: No aberrant methylation (i.e., hypermethylation) was detected in the serum of PC patients who did not also have aberrant methylation of the same promoter in the corresponding tumor sample with one exception for SSBP2, where methylation was detected in serum but not in tumor.